These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 7864708)
1. Appropriate use of heparin. Empiric vs nomogram-based dosing. Gunnarsson PS; Sawyer WT; Montague D; Williams ML; Dupuis RE; Caiola SM Arch Intern Med; 1995 Mar; 155(5):526-32. PubMed ID: 7864708 [TBL] [Abstract][Full Text] [Related]
2. Computer-assisted dosing of heparin. Management with a pharmacy-based anticoagulation service. Kershaw B; White RH; Mungall D; Van Houten J; Brettfeld S Arch Intern Med; 1994 May; 154(9):1005-11. PubMed ID: 8179443 [TBL] [Abstract][Full Text] [Related]
3. A standard heparin nomogram for the management of heparin therapy. Cruickshank MK; Levine MN; Hirsh J; Roberts R; Siguenza M Arch Intern Med; 1991 Feb; 151(2):333-7. PubMed ID: 1789820 [TBL] [Abstract][Full Text] [Related]
4. [Therapeutic infusion of heparin. Application of a nomogram correlated with weight]. Verdiani V; Morettini A; Nozzoli C; Berni G; Sanzo P Recenti Prog Med; 2001 Mar; 92(3):189-92. PubMed ID: 11320849 [TBL] [Abstract][Full Text] [Related]
5. Comparison of a weight-based heparin nomogram with traditional heparin dosing to achieve therapeutic anticoagulation. Shalansky KF; FitzGerald JM; Sunderji R; Traboulay SJ; O'Malley B; McCarron BI; Naiman S Pharmacotherapy; 1996; 16(6):1076-84. PubMed ID: 8947981 [TBL] [Abstract][Full Text] [Related]
6. Utilization and effectiveness of a weight-based heparin nomogram at a large academic medical center. Balcezak TJ; Krumholz HM; Getnick GS; Vaccarino V; Lin ZQ; Cadman EC Am J Manag Care; 2000 Mar; 6(3):329-38. PubMed ID: 10977433 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of an intravenous heparin nomogram in a coronary care unit. Paradiso-Hardy FL; Cheung B; Geerts WH Can J Cardiol; 1996 Sep; 12(9):802-8. PubMed ID: 8842133 [TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Levine MN; Hirsh J; Gent M; Turpie AG; Cruickshank M; Weitz J; Anderson D; Johnson M Arch Intern Med; 1994 Jan; 154(1):49-56. PubMed ID: 8267489 [TBL] [Abstract][Full Text] [Related]
9. Limitations of a standardized weight-based nomogram for heparin dosing in patients with morbid obesity. Barletta JF; DeYoung JL; McAllen K; Baker R; Pendleton K Surg Obes Relat Dis; 2008; 4(6):748-53. PubMed ID: 18586569 [TBL] [Abstract][Full Text] [Related]
10. The effectiveness of implementing the weight-based heparin nomogram as a practice guideline. Raschke RA; Gollihare B; Peirce JC Arch Intern Med; 1996 Aug 12-26; 156(15):1645-9. PubMed ID: 8694662 [TBL] [Abstract][Full Text] [Related]
11. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis. Elliott CG; Hiltunen SJ; Suchyta M; Hull RD; Raskob GE; Pineo GF; Jensen RL; Yeates S; Kitterman N Arch Intern Med; 1994 May; 154(9):999-1004. PubMed ID: 8179457 [TBL] [Abstract][Full Text] [Related]
12. Use of a standardized heparin nomogram to achieve therapeutic anticoagulation after thrombolytic therapy in myocardial infarction. TIMI 4 investigators. Thrombolysis in Myocardial Infarction. Flaker GC; Bartolozzi J; Davis V; McCabe C; Cannon CP Arch Intern Med; 1994 Jul; 154(13):1492-6. PubMed ID: 8018004 [TBL] [Abstract][Full Text] [Related]
13. The successful application of a heparin nomogram in a community hospital. Hollingsworth JA; Rowe BH; Brisebois FJ; Thompson PR; Fabris LM Arch Intern Med; 1995 Oct; 155(19):2095-100. PubMed ID: 7575069 [TBL] [Abstract][Full Text] [Related]
14. Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature. Myzienski AE; Lutz MF; Smythe MA Pharmacotherapy; 2010 Mar; 30(3):324. PubMed ID: 20180615 [TBL] [Abstract][Full Text] [Related]
15. Heparin dosage adjustment in patients with deep-vein thrombosis using heparin concentrations rather than activated partial thromboplastin time. Groce JB; Gal P; Douglas JB; Steuterman MC Clin Pharm; 1987 Mar; 6(3):216-22. PubMed ID: 3665377 [TBL] [Abstract][Full Text] [Related]
16. Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis. Hull RD; Raskob GE; Brant RF; Pineo GF; Valentine KA Arch Intern Med; 1997 Dec 8-22; 157(22):2562-8. PubMed ID: 9531224 [TBL] [Abstract][Full Text] [Related]
17. Use of a heparin nomogram for treatment of patients with venous thromboembolism in a community hospital. de Groot MR; Büller HR; ten Cate JW; van Marwijk Kooy M Thromb Haemost; 1998 Jul; 80(1):70-3. PubMed ID: 9684788 [TBL] [Abstract][Full Text] [Related]
18. Effect of weight, sex, age, clinical diagnosis, and thromboplastin reagent on steady-state intravenous heparin requirements. White RH; Zhou H; Woo L; Mungall D Arch Intern Med; 1997 Nov; 157(21):2468-72. PubMed ID: 9385298 [TBL] [Abstract][Full Text] [Related]
19. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction. Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657 [TBL] [Abstract][Full Text] [Related]
20. Use of the activated partial thromboplastin time for heparin monitoring. Smythe MA; Koerber JM; Westley SJ; Nowak SN; Begle RL; Balasubramaniam M; Mattson JC Am J Clin Pathol; 2001 Jan; 115(1):148-55. PubMed ID: 11190801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]